Published in

Society for Neuroscience, Journal of Neuroscience, 40(35), p. 13568-13576, 2015

DOI: 10.1523/jneurosci.2468-15.2015

Links

Tools

Export citation

Search in Google Scholar

APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

Contrary to Alzheimer's disease (AD), theAPOE2allele increases and theAPOE4allele reduces the risk to develop age-related macular degeneration (AMD) compared with the most commonAPOE3allele. The underlying mechanism for this association with AMD and the reason for the puzzling difference with AD are unknown. We previously demonstrated that pathogenic subretinal mononuclear phagocytes (MPs) accumulate inCx3cr1-deficient mice due to the overexpression of APOE, interleukin-6, and CC chemokine ligand 2 (CCL2). We here show using targeted replacement mice expressing the human APOE isoforms (TRE2,TRE3, andTRE4) that MPs ofTRE2mice express increased levels of APOE, interleukin-6, and CCL2 and develop subretinal MP accumulation, photoreceptor degeneration, and exaggerated choroidal neovascularization similar to AMD. Pharmacological inhibition of the cytokine induction inhibited the pathogenic subretinal inflammation. In the context of APOE-dependent subretinal inflammation inCx3cr1GFP/GFPmice, theAPOE4allele led to diminished APOE and CCL2 levels and protectedCx3cr1GFP/GFPmice against harmful subretinal MP accumulation observed inCx3cr1GFP/GFPTRE3mice. Our study shows that pathogenic subretinal inflammation is APOE isoform-dependent and provides the rationale for the previously unexplained implication of the APOE2 isoform as a risk factor and the APOE4 isoform as a protective factor in AMD pathogenesis.SIGNIFICANCE STATEMENTThe understanding of how genetic predisposing factors, which play a major role in age-related macular degeneration (AMD), participate in its pathogenesis is an important clue to decipher the pathomechanism and develop efficient therapies. In this study, we used transgenic, targeted replacement mice that carry the three human APOE isoform-defining sequences at the mouse APOE chromosomal location and express the human APOE isoforms. Our study is the first to show howAPOE2provokes andAPOE4inhibits the cardinal AMD features, inflammation, degeneration, and exaggerated neovascularization. Our findings reflect the clinical association of the genetic predisposition that was recently confirmed in a major pooled analysis. They emphasize the role of APOE in inflammation and inflammation in AMD.